Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction

Marcin Dobaczewski, Marcin Bujak, Na Li, Carlos Gonzalez-Quesada, Leonardo H. Mendoza, Xaiao Fan Wang, Nikolaos G. Frangogiannis

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

Rationale: Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming growth factor (TGF)-β/Smad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. Objective: The present study explores the mechanisms responsible for the fibrogenic effects of Smad3 by dissecting its role in modulating cardiac fibroblast phenotype and function. Methods and Results: Smad3 null mice and corresponding wild-type controls underwent reperfused myocardial infarction protocols. Surprisingly, reduced collagen deposition in Smad3-/-infarcts was associated with increased infiltration with myofibroblasts. In vitro studies demonstrated that TGF-β1 inhibited murine cardiac fibroblast proliferation; these antiproliferative effects were mediated via Smad3. Smad3-/-fibroblasts were functionally defective, exhibiting impaired collagen lattice contraction when compared with wild-type cells. Decreased contractile function was associated with attenuated TGF-β-induced expression of α-smooth muscle actin. In addition, Smad3-/- fibroblasts had decreased migratory activity on stimulation with serum, and exhibited attenuated TGF-β1-induced upregulation of extracellular matrix protein synthesis. Upregulation of connective tissue growth factor, an essential downstream mediator in TGF-β-induced fibrosis, was in part dependent on Smad3. Connective tissue growth factor stimulation enhanced extracellular matrix protein expression by cardiac fibroblasts in a Smad3-independent manner. Conclusions: Disruption of Smad3 results in infiltration of the infarct with abundant hypofunctional fibroblasts that exhibit impaired myofibroblast transdifferentiation, reduced migratory potential, and suppressed expression of fibrosis-associated genes.

Original languageEnglish (US)
Pages (from-to)418-428
Number of pages11
JournalCirculation Research
Volume107
Issue number3
DOIs
StatePublished - Aug 6 2010
Externally publishedYes

Fingerprint

Transforming Growth Factors
Fibroblasts
Myocardial Infarction
Phenotype
Connective Tissue Growth Factor
Fibrosis
Myofibroblasts
Extracellular Matrix Proteins
Up-Regulation
Collagen
Ventricular Remodeling
Smooth Muscle
Actins
Serum
Genes

Keywords

  • Fibroblasts
  • Fibrosis
  • Growth factors
  • Myocardial infarction
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. / Dobaczewski, Marcin; Bujak, Marcin; Li, Na; Gonzalez-Quesada, Carlos; Mendoza, Leonardo H.; Wang, Xaiao Fan; Frangogiannis, Nikolaos G.

In: Circulation Research, Vol. 107, No. 3, 06.08.2010, p. 418-428.

Research output: Contribution to journalArticle

Dobaczewski, Marcin ; Bujak, Marcin ; Li, Na ; Gonzalez-Quesada, Carlos ; Mendoza, Leonardo H. ; Wang, Xaiao Fan ; Frangogiannis, Nikolaos G. / Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. In: Circulation Research. 2010 ; Vol. 107, No. 3. pp. 418-428.
@article{26af3ae25fe94b7c8e84d7bed45653a2,
title = "Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction",
abstract = "Rationale: Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming growth factor (TGF)-β/Smad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. Objective: The present study explores the mechanisms responsible for the fibrogenic effects of Smad3 by dissecting its role in modulating cardiac fibroblast phenotype and function. Methods and Results: Smad3 null mice and corresponding wild-type controls underwent reperfused myocardial infarction protocols. Surprisingly, reduced collagen deposition in Smad3-/-infarcts was associated with increased infiltration with myofibroblasts. In vitro studies demonstrated that TGF-β1 inhibited murine cardiac fibroblast proliferation; these antiproliferative effects were mediated via Smad3. Smad3-/-fibroblasts were functionally defective, exhibiting impaired collagen lattice contraction when compared with wild-type cells. Decreased contractile function was associated with attenuated TGF-β-induced expression of α-smooth muscle actin. In addition, Smad3-/- fibroblasts had decreased migratory activity on stimulation with serum, and exhibited attenuated TGF-β1-induced upregulation of extracellular matrix protein synthesis. Upregulation of connective tissue growth factor, an essential downstream mediator in TGF-β-induced fibrosis, was in part dependent on Smad3. Connective tissue growth factor stimulation enhanced extracellular matrix protein expression by cardiac fibroblasts in a Smad3-independent manner. Conclusions: Disruption of Smad3 results in infiltration of the infarct with abundant hypofunctional fibroblasts that exhibit impaired myofibroblast transdifferentiation, reduced migratory potential, and suppressed expression of fibrosis-associated genes.",
keywords = "Fibroblasts, Fibrosis, Growth factors, Myocardial infarction, Transforming growth factor-β",
author = "Marcin Dobaczewski and Marcin Bujak and Na Li and Carlos Gonzalez-Quesada and Mendoza, {Leonardo H.} and Wang, {Xaiao Fan} and Frangogiannis, {Nikolaos G.}",
year = "2010",
month = "8",
day = "6",
doi = "10.1161/CIRCRESAHA.109.216101",
language = "English (US)",
volume = "107",
pages = "418--428",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction

AU - Dobaczewski, Marcin

AU - Bujak, Marcin

AU - Li, Na

AU - Gonzalez-Quesada, Carlos

AU - Mendoza, Leonardo H.

AU - Wang, Xaiao Fan

AU - Frangogiannis, Nikolaos G.

PY - 2010/8/6

Y1 - 2010/8/6

N2 - Rationale: Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming growth factor (TGF)-β/Smad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. Objective: The present study explores the mechanisms responsible for the fibrogenic effects of Smad3 by dissecting its role in modulating cardiac fibroblast phenotype and function. Methods and Results: Smad3 null mice and corresponding wild-type controls underwent reperfused myocardial infarction protocols. Surprisingly, reduced collagen deposition in Smad3-/-infarcts was associated with increased infiltration with myofibroblasts. In vitro studies demonstrated that TGF-β1 inhibited murine cardiac fibroblast proliferation; these antiproliferative effects were mediated via Smad3. Smad3-/-fibroblasts were functionally defective, exhibiting impaired collagen lattice contraction when compared with wild-type cells. Decreased contractile function was associated with attenuated TGF-β-induced expression of α-smooth muscle actin. In addition, Smad3-/- fibroblasts had decreased migratory activity on stimulation with serum, and exhibited attenuated TGF-β1-induced upregulation of extracellular matrix protein synthesis. Upregulation of connective tissue growth factor, an essential downstream mediator in TGF-β-induced fibrosis, was in part dependent on Smad3. Connective tissue growth factor stimulation enhanced extracellular matrix protein expression by cardiac fibroblasts in a Smad3-independent manner. Conclusions: Disruption of Smad3 results in infiltration of the infarct with abundant hypofunctional fibroblasts that exhibit impaired myofibroblast transdifferentiation, reduced migratory potential, and suppressed expression of fibrosis-associated genes.

AB - Rationale: Cardiac fibroblasts are key effector cells in the pathogenesis of cardiac fibrosis. Transforming growth factor (TGF)-β/Smad3 signaling is activated in the border zone of healing infarcts and induces fibrotic remodeling of the infarcted ventricle contributing to the development of diastolic dysfunction. Objective: The present study explores the mechanisms responsible for the fibrogenic effects of Smad3 by dissecting its role in modulating cardiac fibroblast phenotype and function. Methods and Results: Smad3 null mice and corresponding wild-type controls underwent reperfused myocardial infarction protocols. Surprisingly, reduced collagen deposition in Smad3-/-infarcts was associated with increased infiltration with myofibroblasts. In vitro studies demonstrated that TGF-β1 inhibited murine cardiac fibroblast proliferation; these antiproliferative effects were mediated via Smad3. Smad3-/-fibroblasts were functionally defective, exhibiting impaired collagen lattice contraction when compared with wild-type cells. Decreased contractile function was associated with attenuated TGF-β-induced expression of α-smooth muscle actin. In addition, Smad3-/- fibroblasts had decreased migratory activity on stimulation with serum, and exhibited attenuated TGF-β1-induced upregulation of extracellular matrix protein synthesis. Upregulation of connective tissue growth factor, an essential downstream mediator in TGF-β-induced fibrosis, was in part dependent on Smad3. Connective tissue growth factor stimulation enhanced extracellular matrix protein expression by cardiac fibroblasts in a Smad3-independent manner. Conclusions: Disruption of Smad3 results in infiltration of the infarct with abundant hypofunctional fibroblasts that exhibit impaired myofibroblast transdifferentiation, reduced migratory potential, and suppressed expression of fibrosis-associated genes.

KW - Fibroblasts

KW - Fibrosis

KW - Growth factors

KW - Myocardial infarction

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=77956627158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956627158&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.109.216101

DO - 10.1161/CIRCRESAHA.109.216101

M3 - Article

VL - 107

SP - 418

EP - 428

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 3

ER -